Other Information
−Removed: See the section entitled “Compliance with Nasdaq Listing Standards” in Item 2 of Part I of this Quarterly
−Removed: Report on Form 10-Q for details regarding our noncompliance with the Nasdaq listing rules.
−Removed: The following exhibits are filed herewith or are incorporated
−Removed: by reference to exhibits previously filed with the SEC.
+Added: following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the SEC.
+Added: Certificate of Designation of Preferences, Rights and Limitations of the Series D Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 1, 2025)
+Added: Certificate of Designation of Preferences, Rights and Limitations of the Series C Convertible Preferred Stock (incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K filed with the SEC on July 1, 2025)
+Added: Certificate of Third Amendment to the Amended and Restated Certificate of Incorporation of Biofrontera Inc., filed June 16, 2025
+Added: Form of Securities Purchase Agreement, dated June 27, 2025, by and among Biofrontera Inc.
+Added: and the purchasers named therein (incorporated by reference to Exhibit 10.1 of the Company’s Current Report on Form 8-K filed with the SEC on July 1, 2025)
+Added: Form of Agreement, dated June 30, 2025, by and among Biofrontera Inc.
+Added: and Biofrontera AG (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form 8-K/A filed with the SEC on July 16, 2025)
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes Oxley Act of 2002
2 unchanged sentences
Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes Oxley Act of 2002
−Removed: Inline XBRL Instance Document
−Removed: Inline XBRL Taxonomy Extension Schema Document
−Removed: Inline XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Definition Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Label Linkbase Document
−Removed: Inline XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)
+Added: XBRL Instance Document
+Added: XBRL Taxonomy Extension Schema Document
+Added: XBRL Taxonomy Extension Calculation Linkbase Document
+Added: XBRL Taxonomy Extension Definition Linkbase Document
+Added: XBRL Taxonomy Extension Label Linkbase Document
+Added: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)
Filed herewith.
+Added: Indicates a management
+Added: contract or compensatory plan or arrangement.
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
−Removed: BIOFRONTERA INC.
−Removed: /s/ Hermann Luebbert
+Added: August 13, 2025
Hermann Luebbert
−Removed: Chief Executive Officer & Chairman
−Removed: ( Principal Executive Officer)
+Added: Hermann Luebbert
+Added: Executive Officer & Chairman
+Added: Executive Officer)
+Added: August 13, 2025
Fred Leffler III
Fred Leffler, III
−Removed: Chief Financial Officer
−Removed: (Principal Financial Officer)
+Added: Financial Officer
+Added: Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.